Search

Author/Creator Redondo, Isabel

1. P13 Communicating needs and features of IBD experiences (CONFIDE) survey: patient and health care professional perspectives. (19th June 2022)

Authors:
Redondo, Isabel; Rubin, David; Panaccione, Remo; Bleakman, Alison Potts; Kayhan, Cem; Atkinson, Christian; Gibble, Theresa Hunter; Ellis, Hilary; Healey, Kristine; Shan, Mingyang; Hibi, Toshifumi; Chaudhury, Koyel
Journal:
Gut
Issue:
Volume 71(2022)Supplement 1
Page Start:
A42
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S755 Early Symptom Control With Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis in the LUCENT-1 Induction Trial. (October 2022)

Authors:
Danese, Silvio; Dignass, Axel; Matsuoka, Katsuyoshi; Ferrante, Marc; Redondo, Isabel; Gibble, Theresa Hunter; Moses, Richard; Morris, Nathan; Li, Xingyuan; Milch, Catherine; Abreu, Maria T.
Other Names:
Long Millie presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e535
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. S759 Efficacy and Safety of Mirikizumab in Patients With Ulcerative Colitis: 104-Week Results From a Phase 2 Randomized Controlled Trial. (October 2021)

Authors:
Panaccione, Remo; Feagan, Brian G.; Redondo, Isabel; Lissoos, Trevor; Selinger, Christian; Arora, Vipin; Lukas, Milan; Matsuoka, Katsuyoshi; Hibi, Toshifumi
Journal:
American journal of gastroenterology
Issue:
Volume 116:Supplement(2021)ACG Annual Meeting Abstracts 1
Page Start:
S350
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. S766 The Effect of Mirikizumab on Fecal Calprotectin and C-Reactive Protein in Phase 3 Studies of Patients With Moderately-to-Severely Active Ulcerative Colitis. (October 2022)

Authors:
Siegmund, Britta; Samaan, Karen; Li, Xingyuan; Morris, Nathan; Gibble, Theresa Hunter; Redondo, Isabel; Lissoos, Trevor; D'Haens, Geert
Other Names:
Sands Bruce E. presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e543
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S784 Sustained Symptom Control With Mirikizumab in Patients With Moderately-to-Severely Active Ulcerative Colitis in the LUCENT-2 Maintenance Trial. (October 2022)

Authors:
Dignass, Axel; Danese, Silvio; Matsuoka, Katsuyoshi; Ferrante, Marc; Redondo, Isabel; Gibble, Theresa Hunter; Moses, Richard; Li, Xingyuan; Morris, Nathan; Milch, Catherine; Abreu, Maria T.
Other Names:
Long Millie presenter.
Journal:
American journal of gastroenterology
Issue:
Volume 117:Number 10(2022)supplement 10S
Page Start:
e558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab. (August 2019)

Authors:
Magro, Fernando; Lopes, Susana; Silva, Marco; Coelho, Rosa; Portela, Francisco; Branquinho, Diogo; Correia, Luís; Fernandes, Samuel; Cravo, Marília; Caldeira, Paulo; Tavares de Sousa, Helena; Patita, Marta; Lago, Paula; Ramos, Jaime; Afonso, Joana; Redondo, Isabel; Machado, Patrícia; Philip, Geor...
Journal:
Therapeutic advances in gastroenterology
Issue:
Volume 12(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗